Publications & Podcasts

New DOJ Task Force Announced Will Impact Health Care Providers & Prescribers in Northern New England

June 29, 2022 Alerts and Newsletters

Major enforcement news was released today, Wednesday, June 29, 2022, for medical professionals and anyone working in or around the health care space in Maine, New Hampshire, and Vermont.

The United States Department of Justice (DOJ) announced the formation of a new "Strike Force" to investigate physicians, pharmacists and medical professionals related to allegations of health care fraud and diversion in New Hampshire, Maine, and Vermont. The task force will contain representatives from United States Attorney’s Offices in Maine, New Hampshire, and Vermont, as well as the Health Care Fraud Unit in the Criminal Division’s Fraud Section based in Washington, D.C., and law enforcement partners at the U.S. Department of Health and Human Services Office of the Inspector General (HHS-OIG), U.S. Drug Enforcement Administration (DEA), and the Federal Bureau of Investigation (FBI).

This regional strike force model has been used by the DOJ in other jurisdictions, which resulted in significant enforcement activity – mostly against providers – including investigations, prosecutions, and seizure of assets.

Unfortunately, if history is a guide, the government’s investigations may go beyond intentional wrongdoers and may sadly extend to other legitimate businesses operating in this space and doing nothing untoward.

The Northern New England task force will be eager to demonstrate its prowess in the region in the near term. The task force will likely harness a robust in-house data analytics team to evaluate prescribing practices, including evaluating outliers. The task force’s presence will likely also lead to an increased focus on state and federal false claims act investigations.

Now is a good time for providers and prescribers to review record keeping and compliance practices.

Relatedly, this week in Xiulu Ruan v. United States, the Supreme Court clarified and strengthened the amount and type of proof required to convict a prescriber of distributing controlled substances for other than a legitimate medical purpose or outside the usual course of professional medical practice. Now, the government must face the tough task of proving beyond a reasonable doubt that a prescriber knowingly or intentionally acted in an unauthorized manner when making a medical decision. A good defense team will need to understand Ruan and its likely effect on false claims act litigation and criminal prosecutions.

Verrill has a team of seasoned White-Collar Defense, Trial, and Health Care lawyers in Maine, Massachusetts, and Connecticut, including a former senior DOJ lawyer who pioneered opioid prosecutions for the government and worked closely with the Strike Force model in other jurisdictions. Our robust and multi-disciplinary team understands how the DOJ may go about building, assessing, and prosecuting these cases.

For more information on how to prepare for, or respond to, any government interaction, or if you are contacted by a member of law enforcement, please contact Verrill Partner David Lazarus or another member of Verrill’s team.

Firm Highlights

Event

Annual Update: The Legal Year in Review

More details coming soon!

News

82 Verrill Attorneys Recognized by Best Lawyers® 2024, Including 10 Named Lawyers of the Year

Blog

Retiree Medical Coverage: Just Get the COBRA Waiver

The interaction between employer-provided retiree medical coverage and COBRA [1] is complex. Many employers incorrectly assume they do not have to offer COBRA at retirement if they offer a retiree medical plan or a...

News

Gratitude for Anya Endsley

Event

Conducting Workplace Investigations

Join Verrill’s Erik Peters and Elizabeth Johnston on Wednesday, October 18, for Conducting Workplace Investigations. When and why should you open an investigation? Who is the best person to conduct it? Should you handle...

Publication/Podcast

Corporate Transparency Act regulations will go into effect soon and will affect almost all startup companies

On August 18, the Maine Venture Fund published an article by Verrill Partner Gregory Fryer, “Corporate Transparency Act regulations will go into effect soon and will affect almost all startup companies.” In the article...

Matter

Successful Representation of Insurer before U.S. District Court for the District of Maine

Verrill successfully represented an insurer before the U.S. District Court for the District of Maine in an insurance coverage matter alleging that the insurer improperly denied a defense and indemnification to a landlord under...

Publication/Podcast

Five Recommended Practices for ERISA Retirement Plan Administrative Fiduciaries

Verrill’s Employee Benefits & Executive Compensation Group is often asked about “best practices” for benefit plan administration and whether we can provide any resources to help plan sponsors and fiduciaries improve compliance with the...

Blog

How AI Can Alter Skill Contests

AI could very well be today’s “Modern Prometheus” in the world of skill contests. Earlier this year, the AI-generated photograph “The Electrician” was a finalist in the World Photograph Organization’s Sony World Photograph Awards...

Matter

Elections and Constitutional Law: Successfully Challenged Certification of Initiative Petition

In a victory for consumers and the ride-hailing public, the Massachusetts Supreme Judicial Court recently barred the Secretary of State from placing on the November ballot initiative petitions proposed by companies such as Uber...

Contact Verrill at (855) 307 0700